« Previous
Next »
European Journal of Cancer
Volume 45, Issue 1
, Pages
74-81
, January 2009
Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: An EU-FP6 supported study of members of the EORTC – PathoBiology Group
-
First EQA round. (A) Intra-laboratory CV for each participant per assay. (B) Inter-laboratory CV of samples that were reverse-transcribed by the participants according to their in-house RT protocol or
First EQA round. (A) Intra-laboratory CV for each participant per assay. (B) Inter-laboratory CV of samples that were reverse-transcribed by the participants according to their in-house RT protocol or by the central EQA laboratory.
-
Second EQA round: intra-laboratory CV for each participant, either per assay (A) or on average for all assays (B). 1–5 denote the different participants. (C) Inter-laboratory CVs per assay.Second EQA round: intra-laboratory CV for each participant, either per assay (A) or on average for all assays (B). 1–5 denote the different participants. (C) Inter-laboratory CVs per assay.
-
Third EQA round: intra-laboratory CV for each participant, either per assay (A) or on average for all assays (B). 1–5 denote the different participants. (C) Inter-laboratory CVs per assay. PITX2A andThird EQA round: intra-laboratory CV for each participant, either per assay (A) or on average for all assays (B). 1–5 denote the different participants. (C) Inter-laboratory CVs per assay. PITX2A and B2M values for participant 4 are missing.
-
(A) Harmonisation factors for the different assays and participants. (B) Effect of harmonisation of data on inter-laboratory CV per assay. (C) Effect of normalisation – using reference gene expression(A) Harmonisation factors for the different assays and participants. (B) Effect of harmonisation of data on inter-laboratory CV per assay. (C) Effect of normalisation – using reference gene expression – of data on inter-laboratory CV per assay.
PII: S0959-8049(08)00790-9
doi: 10.1016/j.ejca.2008.09.030
© 2008 Elsevier Ltd. All rights reserved.
« Previous
Next »
European Journal of Cancer
Volume 45, Issue 1
, Pages
74-81
, January 2009
